Andrea R. Daamen

机构：Ampel BioSolutions (United States) · ORCID：0000-0002-0301-2811

发表论文 34 篇 · 总被引 344 次 · h-index 9

代表论文

• Potential and pitfalls of repurposing the CAR-T cell regimen for the treatment of autoimmune disease (2024 · Annals of the Rheumatic Diseases · 被引 19)
• Glucose oxidation-dependent survival of activated B cells provides a putative novel therapeutic target for lupus treatment (2023 · iScience · 被引 19)
• The interferon-rich skin environment regulates Langerhans cell ADAM17 to promote photosensitivity in lupus (2024 · eLife · 被引 15)
• COVID-19 patients exhibit unique transcriptional signatures indicative of disease severity (2022 · Frontiers in Immunology · 被引 13)
• Single-cell RNA sequencing analysis reveals the heterogeneity of IL-10 producing regulatory B cells in lupus-prone mice (2023 · Frontiers in Immunology · 被引 10)
• Classification of COVID-19 Patients into Clinically Relevant Subsets by a Novel Machine Learning Pipeline Using Transcriptomic Features (2023 · International Journal of Molecular Sciences · 被引 10)